Get yourself updated on key emerging technology markets

Know about our market intelligence coverage in key sectors

Product is added to your Wishlist
Global Prefilled Syringes Market

Global Prefilled Syringes Market, Analysis & Forecast, 2017-2021 (Focus on Type, Design, Material both (Value & Volume) and Patent Landscape)

The global market for prefilled syringes is expected to grow at a CAGR of 10.75% from 2017 to 2021, to reach a value of $XX million in 2021. In terms of volume, the market for prefilled syringes is anticipated to reach 8320.6 million units in 2021, growing at a CAGR of 12.31% during the forecast period 2017 to 2021.

SKU: BH022A
Published Year: 2017
 
 

Prefilled syringes have currently emerged as one of the fastest growing choices for unit dose medication since the pharmaceutical industry attempts to explore modern and more convenient drug delivery methods for application. With the evolution of prefilled syringes, pharmaceutical companies are able to efficiently minimize the drug waste and increase product life span, while the patients are able to self-administer injectable drugs at their homes instead of hospitals. Prefilled syringes represent one of the fastest emergent segment among the injectable drug delivery devices market. The primarily factors associated with the use of prefilled syringes are ease of administration, condensed risk of cross contamination, a reduced amount of overfill and ease of treatment.

This research study includes an extensive analysis of the prefilled syringes market, by product type, material, design and geographical regions, allowing the researcher to develop a comprehensive outlook of the market. The two major segments described in the study are glass-based and plastic-based prefilled syringes. Each of these segments has been analyzed on the basis of their current and future market size and market volume, considering the macro and micro environmental factors.

The market report presents a detailed and investigative study of the entire market and provides a comprehensive insight into various forms of developments, trends and key market participants. While highlighting the key driving and restraining forces for this dynamic market, the report also provides a comprehensive section on competitive landscape, market share analysis, competitive benchmarking, and the position of competitors within the global prefilled syringe market. 

The following key questions have been addressed in the report:

  • What are the major market drivers, challenges and opportunities of the global prefilled syringes market?
  • How is the prefilled syringes market evolving during the forecast period?
  •  What are the driving and restraining factors in the prefilled syringes market?
  • What are the market shares of the leading segments and sub-segments of the global prefilled syringes market in 2016 and 2023?
  • How will each segment of the prefilled syringes market grow over the forecast period and how much revenue will these account for in 2023?
  • How will the market share of the leading companies change in 2017 and which country will lead the market in 2017?
  • How will the industry evolve during the period between 2017 and 2023?
  • What are the key developmental strategies implemented in different types across all regions?
  •  Which geographical region will lead the global prefilled syringes market by the end of the forecast period?
  • What are the market trends and key developments in this market?

The report includes the profiles of major players in the market that allows the readers to get an insight into the various industry trends.  Some of the leading companies in the market are Gerresheimer AG, Schott AG, Stevanato Group, Baxter International, Inc., Unilife Corporation, Terumo Corporation, West Pharmaceuticals, Inc., Vetter pharmaceuticals and Becton Dickinson and Co. 

TABLE OF CONTENT
Executive Summary
1 Research Scope and Methodology
1.1 Scope of the Report
1.2 Global GERD Therapy Market Segmentation
1.3 Key Objectives
1.4 Research Methodology
1.4.1  Data Triangulation
1.4.2  Secondary Sources
1.4.3 Primary Sources
1.4.4   Top-Down  Approach
1.4.5   Bottom-Up Approach
1.4.6  Assumptions and Limitations
1.4.7   Data and Prediction Modelling
2 Market Overview
2.1 Introduction
2.2 Advantages of Prefilled Syringes over traditional vial & syringe system
2.3 Manufacturing & Packaging Challenges of Prefilled Syringes
2.4 Benefits of prefilled syringes to the drug makers
2.5 Technology Trends in  Market
2.6 Legal Requirements and Regulations
2.7 Patent Analysis
3 Market Dynamics
3.1 Drivers
3.2 Challenges
3.. Opportunities
4 Competitive Landscape
4.1 Key Market Development and Strategies
4.1.1 Mergers and Acquisition
4.1.2 Product Launch & Developments
4.1.3 Partnerships, Collaborations & Joint Ventures
4.1.4 Business Expansions and Contracts
4.2 Market Share Analysis
4.3 Industry Attractiveness
5 Industry Analysis
5.1 Regulatory Bodies and Associations
5.2 Patent Landscape
6 Global Prefilled Syringes by Type, 2016-2023 (Qualitative)
6.1 Overview
6.2 Conventional Prefilled Syringes
6.3 Safety Prefilled Syringes
7 Global Prefilled Syringes by Design, 2016-2023 (Qualitative)
7.1 Overview
7.2 Single-Chamber Prefilled Syringes
7.3 Dual-Chamber Prefilled Syringes
7.4 Customized Prefilled Syringes
8 Global Prefilled Syringes by Material Revenue ($Million) and Volume (Million Units), 2016-2023
8.1 Overview
8.2 Glass Prefilled Syringes
8.3 Plastic Prefilled Syringes
9 Global Prefilled Syringes Market by Region, Revenue ($Million) and Volume (Million Units), 2016-2023 
9.1 Overview
9.2 North America
9.3 Europe
9.4 Asia Pacific (APAC)
9.5 Rest of the World (RoW)
10 Company Profiles
10.1 Baxter International
10.2 Becton Dickinson & Company
10.3 Bristol Myers Squibb
10.4 Eli Lilly
10.5 Gerresheimer
10.6 Medtronic Inc.
10.7 Nipro Corporation
10.8 Pfizer
10.9 SCHOTT AG
10.10 Stevanto Group
10.11 Terumo Corporation
10.12 Unilife Corporation
10.13 Vetter Pharmaceuticals GmBH
10.14 Weigao Group
10.15 West Pharmaceutical Services
10.16 Snapshot of Other Key Players
List of Tables
1 Global Prefilled Syringe Market Snapshot
2 Components of Prefilled Syringes
3 New Product Launches, Developments and Testings
4 Patents, Approvals and Certifications
5 Mergers, Acquisitions and Business Expansion/Contracts 
6 Collaborations, joint Ventures and Partnerships
7 Other Strategies
8 Patents Landscape
9 Consortiums, Associations and Regulatory Bodies
10 Some of the Lyophilized Drugs Used in Prefilled Syringe Format 
11 Some of the Recently Marketed Prefilled Safety Syringes Technologies
12 Some of the Dual Chamber Prefilled Syringes
13 Baxter International: Overview 
14 Becton Dickinson & Company: Overview 
15 Bristol Myers Squibb: Overview 
16 Eli Lilly: Overview 
17 Gerresheimer: Overview 
18 Medtronic Inc.: Overview 
19 Nipro Corporation: Overview 
20 Pfizer: Overview 
21 SCHOTT AG: Overview 
22 Stevanato Group: Overview 
23 Terumo Corporation: Overview 
24 Unilife Corporation: Overview 
25 Vetter Pharmaceuticals GmBH: Overview 
26 Weigao Group: Overview 
27 West Pharmaceutical Services: Overview 
List of Figures
1 Global Prefilled Syringe Market by Value , 2016-2021 ($Million)
2 Global Prefilled Syringe Market by Volume, 2016-2021  (in Units)
3 Prefilled Syringe Market Value by  Type, 2016
4 Prefilled Syringe Market Value by  Type, 2021
5 Prefilled Syringe Market Volume by Type, 2016
6 Prefilled Syringe Market Volume by Type, 2021
7 Global Prefilled Syringe Market Value by Geography, 2016 & 2021 ($Million)
8 Market Segmentation
9 Research Methodology
10 Top-Down  Approach
11 Bottom-Up Approach 
12 Assumptions and Limitations
13 Advantages of Prefilled Syringes Over Traditional Vial & Syringe System
14 Recent Market Development Strategy Snapshot Analysis
15 Key Market Developemnts & Strategies
16 Market Share Analysis, 2015
17 Market Share Analysis, 2016
18 Market Attractiveness Analysis: Global Prefilled Syringes Market, by Geography (2016)
19 Growth Share Matrix by Region
20 Global Prefilled Syringes Market, By Products
21 Global Prefilled Syringes Market, By Design
22 Global Prefilled Syringes Market, By Material
23 Global Prefilled Syringes Market Value, By Material (2016-2021)
24 Global Prefilled Syringes Market Volume, By Material (2016-2021)
25 Significant Advantages of Plastic over Glass in Prefilled Syringes
26 Global Glass Prefilled Syringes Market Volume (2016-2021)
27 Global Glass Prefilled Syringes Market Value (2016-2021)
28 Global Plastic Prefilled Syringes Market Volume (2016-2021)
29 Global Plastic Prefilled Syringes Market Value (2016-2021)
30 Global Prefilled Syringes Market by Geography 
31 Global Prefilled Syringe Market Value by Geography, 2016-2021  ($Million)
32 Global Prefilled Syringe Market Volume by Geography, 2016-2021  (Million Units)
33 North America Prefilled Syringe Market, 2016-2021 (in Units)
34 North America Prefilled Syringe Market, 2016-2021 ($Million)
35 North America Prefilled Syringe Market by Country, 2016-2021 (in Units)
36 North America Prefilled Syringe Market by Country, 2016-2021 ($Million)
37 Europe Prefilled Syringe Market, 2016-2021 (in Units)
38 Europe Prefilled Syringe Market, 2016-2021 ($Million)
39 Europe Prefilled Syringe Market by Country, 2016-2021 (in Units)
40 Europe Prefilled Syringe Market by Country, 2016-2021 ($Million)
41 APAC Prefilled Syringe Market, 2016-2021 (in Units)
42 APAC Prefilled Syringe Market, 2016-2021 ($Million)
43 APAC Prefilled Syringe Market by Country, 2016-2021 (in Units)
44 APAC Prefilled Syringe Market by Country, 2016-2021 ($Million)
45 RoW America Prefilled Syringe Market, 2016-2021 (in Units)
46 RoW Prefilled Syringe Market, 2016-2021 ($Million)
47 RoW Prefilled Syringe Market by Country, 2016-2021 (in Units)
48 RoW Prefilled Syringe Market by Country, 2016-2021 ($Million)
49 Baxter International: Overall Financials, 2013-2016
50 Baxter International: Revenues across Different Geographies, 2013-2016
51 Baxter International: Net Revenue by Business Segment, 2013-2016
52 Baxter International: SWOT Analysis
53 Becton Dickinson & Co.: Overall Financials, 2013-2016
54 Becton Dickinson & Co.: Revenues across Different Geographies, 2013-2016
55 Becton Dickinson & Co.: Net Revenue by Business Segment, 2013-2016
56 Becton Dickinson & Co.: SWOT Analysis
57 Bristol Myers Squibb: Overall Financials, 2013-2016
58 Bristol Myers Squibb: Revenues across Different Geographies, 2013-2016
59 Bristol Myers Squibb: Net Revenue by Business Segment, 2013-2016
60 Bristol Myers Squibb: SWOT Analysis
61 Eli Lilly: Overall Financials, 2013-2016
62 Eli Lilly: Revenues across Different Geographies, 2013-2016
63 Eli Lilly: Net Revenue by Business Segment, 2013-2016
64 Eli Lilly: SWOT Analysis
65 Gerresheimer: Overall Financials, 2013-2016
66 Gerresheimer: Revenues across Different Geographies, 2013-2016
67 Gerresheimer: Net Revenue by Business Segment, 2013-2016
68 Gerresheimer: SWOT Analysis
69 Medtronic Inc.: Overall Financials, 2013-2016
70 Medtronic Inc.: Revenues across Different Geographies, 2013-2016
71 Medtronic Inc.: Net Revenue by Business Segment, 2013-2016
72 Medtronic Inc.: SWOT Analysis
73 Nipro Corporation: Overall Financials, 2013-2016
74 Nipro Corporation: Revenues across Different Geographies, 2013-2016
75 Nipro Corporation: Net Revenue by Business Segment, 2013-2016
76 Nipro Corporation: SWOT Analysis
77 Pfizer: Overall Financials, 2013-2016
78 Pfizer: Revenues across Different Geographies, 2013-2016
79 Pfizer: Net Revenue by Business Segment, 2013-2016
80 Pfizer: SWOT Analysis
81 SCHOTT AG: Overall Financials, 2013-2016
82 SCHOTT AG: Revenues across Different Geographies, 2013-2016
83 SCHOTT AG: Net Revenue by Business Segment, 2013-2016
84 SCHOTT AG: SWOT Analysis
85 Stevanato Group: Overall Financials, 2013-2016
86 Stevanato Group: Revenues across Different Geographies, 2013-2016
87 Stevanato Group: Net Revenue by Business Segment, 2013-2016
88 Stevanato Group: SWOT Analysis
89 Terumo Corporation: Overall Financials, 2013-2016
90 Terumo Corporation: Revenues across Different Geographies, 2013-2016
91 Terumo Corporation: Net Revenue by Business Segment, 2013-2016
92 Terumo Corporation: SWOT Analysis
93 Unilife Corporation: Overall Financials, 2013-2016
94 Unilife Corporation: Revenues across Different Geographies, 2013-2016
95 Unilife Corporation: Net Revenue by Business Segment, 2013-2016
96 Unilife Corporation: SWOT Analysis
97 Vetter Pharmaceuticals GmBH: Overall Financials, 2013-2016
98 Vetter Pharmaceuticals GmBH: Revenues across Different Geographies, 2013-2016
99 Vetter Pharmaceuticals GmBH: Net Revenue by Business Segment, 2013-2016
100 Vetter Pharmaceuticals GmBH: SWOT Analysis
101 Weigao Group: Overall Financials, 2013-2016
102 Weigao Group: Revenues across Different Geographies, 2013-2016
103 Weigao Group: Net Revenue by Business Segment, 2013-2016
104 Weigao Group: SWOT Analysis
105 West Pharmaceutical Services: Overall Financials, 2013-2016
106 West Pharmaceutical Services: Revenues across Different Geographies, 2013-2016
107 West Pharmaceutical Services: Net Revenue by Business Segment, 2013-2016
108 West Pharmaceutical Services: SWOT Analysis

Prefilled syringes are increasingly witnessed as a primary choice for most of the high-end injectable drugs due to various advantages they offer over traditional packaging systems. A prefilled syringe is a single dose primary sterile container and delivery system that is filled aseptically with an injectable drug and sold for parenteral administration of drugs to patients. Anticoagulants, antivirals, anaphylaxis, hematopoietic, monoclonal antibodies and vaccines are the most commonly used therapeutic categories in the prefilled syringe format. Nowadays, with the help of prefilled syringes, pharmaceutical companies are able to minimize the drug waste and increase product life span, while the patients are able to self-administer injectable drugs at their home instead of the hospitals.

Despite the high paced competition in the global prefilled syringes market, future prospective growth is expected to be driven by favorable factors such as accurate drug dosing, negligible overfill requirements, no preservatives required in the formulation, increased assurance of sterility, ease of use and handling, time saving in emergency situations, and reduced material cost, among others, which are some of the major advantages provided by prefilled syringes. As a result, prefilled syringes represent one of the fastest growing segments among the injectable drug delivery devices market.

The prefilled syringes market is growing exponentially worldwide due to the increase in prevalence of chronic diseases, growing demand and higher production of large molecule biologics and biosimilars, high penetration rate of self-injection devices and continuous advancement in prefilled syringes with the inclusion of autonomous inbuilt safety mechanisms. The global prefilled syringes market has been segmented into four major regions namely, North America, Europe, Asia-Pacific and Rest of the World (RoW).The European and North American markets are dominant in terms of market share, which is attributed to the presence of leading prefilled syringes and biological drug manufacturing players in both the regions.

Syringe manufacturers provide prefillable syringes in pre-sterilized or bulk forms to drug manufacturers for filling of various categories of injectable drugs including anticoagulants, vaccines, antivirals, hematopoietics, monoclonal antibodies and some other emergency drugs. The global market for prefilled syringes is expected to grow at a CAGR of 10.75% from 2017 to 2021, to reach a value of $XX million in 2021. In terms of volume, the market for prefilled syringes is anticipated to reach 8320.6 million units in 2021, growing at a CAGR of 12.31% during the forecast period 2017 to 2021.

Europe dominated the global market in 2016 with a share of XX%. Its market size by volume was estimated to be XX million units in 2016 and is projected to reach XX million units by 2021, registering a CAGR of XX% between 2017 and 2021. However, the Asia Pacific is estimated to show highest growth with a CAGR of XX% from 2017 to 2021.

The global glass prefilled syringe market value is accounted to be $XX million in 2016 and is projected to reach $XX million   by 2021, registering a CAGR of XX % between 2017 and 2021.

The increasing demand for safety plastic prefilled syringes due to its convenience and cost effectiveness have obligated companies to focus on new product developments and innovations. The most prominent opportunity for the industry players is market penetration in emerging markets such as Japan, China, Australia and India. Currently, the market is dominated by Europe due to the presence of established prefilled syringe and biological drug manufacturers based in Europe. However, stringent regulatory standards regarding combination products and high manufacturing cost of prefilled syringes are hampering the growth of the market. Market penetration, establishment and outreach of major key players in the emerging markets, and increasing biologics and bio-similar in the market will serve as viable opportunities for the market players to enhance their business in the future.

The key players are Gerresheimer AG, Schott AG, Stevanato Group, Baxter International, Inc., Unilife Corporation, Terumo Corporation, West Pharmaceuticals, Inc., Vetter pharmaceuticals and Becton Dickinson and Co, among others.

We understand that your business need specific answers pertaining to the market. And , therefore, we do provide customised research tailored to your need.

With the purchase of this report, you are entitled to certain degree of free customisation within the scope of the study.

Do get in touch to help us understand how we can serve u better with a custom solution to your research needs. We assure quick turnaround for your pressing business requirements.

Contact Information


Name *
Email *
 
Company Name *
Designation
 
 
Contact No. *
Other Details
 
 
 
* Required Fields

OUR HAPPY CLIENTS


related reports

 

OUR CLIENTS